APC and colorectal cancer: Colorectal cancer (CRC) development is characterized by stepwise accumulation of mutations, of which the majority display early mutations in tumor suppressor gene APC.1 Previous work revealed that Apc loss confers a competitive advantage to mutant intestinal stem cells (ISCs), which consequently replace all normal ISCs and drive crypt fixation in vivo.2